Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy

Exclusion Criteria

• •Any metabolic conditions that might increase the risks associated with trial participation or investigational product administration, such as hepatic enzyme elevation greater than twice normal and/or a GFR \< 60 mL/min/1.73 m2 or electrolyte imbalance.
• •* Patients who are currently using or used antibiotics therapy in the preceding month
• •* Patients who are currently using or used other probiotic products in the preceding two weeks
• •* Patients scheduled to undergo GIT surgery or those who underwent GIT surgery
• •* Patients with a Known allergy to probiotics.
• •* Patients receiving artificial enteral or intravenous nutrition